SFTSV induces liver ferroptosis through m6A-related ferritinophagy
Autophagy · 02.11.2025 · 21 (11) · 2353-2366
DOI: 10.1080/15548627.2025.2503564 ↗Kurz gefasst
Fachartikel in der Zeitschrift Autophagy, online erschienen am 14.05.2025. Verfasst von Bingxin Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Public Health Research, Medical School of Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Ferroptosis, Ferritins, Liver, Phlebovirus. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Severe fever with thrombocytopenia syndrome (SFTS) is a widely prevalent infectious disease caused by severe fever with thrombocytopenia syndrome virus (SFTSV). SFTSV infection carries a high mortality rate and has emerged to be a public health concern. SFTSV infection could induce many classical cell death pathways. Ferroptosis, a novel iron-dependent form of regulated cell death, is shown to participate in various biological processes and is considered as a new therapeutic target. In the current study, we reported that SFTSV infection perturbed the classical redox cycle by downregulating the expression of GPX4, SLC7A11 and GSH, and increasing the level of reactive oxygen species (ROS) and malondialdehyde (MDA). Interestingly, we observed that the elevation of ATG5 mRNA m6A modification after SFTSV infection and mutation of the m6A-sites significantly rescued SFTSV infection-induced ferritinophagy. We further found that the NSs protein of SFTSV played a major role in driving the ferritinophagy. Finally, we found that ferroptosis inhibitor ferrostatin-1 prevented ferroptosis and suppressed SFTSV infection both in vitro and in vivo models. In summary, our study demonstrated that SFTSV infection could induce ferroptosis in liver, and m6A modified ATG5 mediated ferritinophagy to facilitate this process. Targeting ferroptosis may serve as a potential therapy for the treatment of SFTS.Abbreviations: ATG5: autophagy related 5; Baf-A1: bafilomycin A1; Fer-1: ferrostatin-1; Fe2+: ferrous iron; FTH1: ferritin heavy chain 1; GOT1/AST: glutamic-oxaloacetic transaminase 1; GPT/ALT: glutamic - pyruvic transaminase; GSH: glutathione; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MDA: malondialdehyde; NCOA4: nuclear receptor coactivator 4; ROS: reactive oxygen species; SFTSV: severe fever with thrombocytopenia virus; SQSTM1/p62: sequestosome 1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Public Health Research, Medical School of Nanjing University, Nanjing, China.
- The Department of Immunology, Huadong Medical Institute of Biotechnique, Nanjing, China.
- State Key Laboratory of Analytical Chemistry for Life Q2 Science, Nanjing University, Nanjing, China.
- School of Pharmacy, Dali University, Dali, Yunnan, China.
ORCID-Profile: Zhiwei Wu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, B., Tian, X., Li, L., Jiang, N., Cheng, M., Zhu, J., & Wu, Z. (2025). SFTSV induces liver ferroptosis through m6A-related ferritinophagy. Autophagy, 21(11), 2353-2366. https://doi.org/10.1080/15548627.2025.2503564
Vancouver
Liu B, Tian X, Li L, Jiang N, Cheng M, Zhu J, et al. SFTSV induces liver ferroptosis through m6A-related ferritinophagy. Autophagy. 2025;21(11):2353-2366. doi:10.1080/15548627.2025.2503564
BibTeX
@article{Liu2025,
author = {Liu, Bingxin and Tian, Xiaoyan and Li, Linrun and Jiang, Na and Cheng, Min and Zhu, Jin and Wu, Zhiwei},
title = {SFTSV induces liver ferroptosis through m6A-related ferritinophagy},
journal = {Autophagy},
year = {2025},
volume = {21},
number = {11},
pages = {2353--2366},
doi = {10.1080/15548627.2025.2503564}
}
EUVIMED